side effects of compound tirzepatide Does Cause Flu-Like Symptoms? What Patients Should Know Compounded Tirzepatide Side Effects |

Blood 127 , 28332840 (2016)

Retatrutide is an investigational triple agonist peptide targeting GIP, GLP-1, and glucagon receptors, currently under clinical development for the management of obesity and type 2 diabetes

Clinical results: Phase 2 monotherapy (Lancet 2021, n=706, 26 weeks): 10.8% weight loss at 4.5 mg/week dose

I didnt even look like the same person

Zabihi pointed to a recent report that cited 60% of patients stopped using their GLP-1 medication before reaching their targeted duration, largely due to negative side effects like stomach pain and nausea

Angiogenesis (Blood Vessel Formation) One of the more interesting mechanisms is its ability to promote angiogenesisthe formation of new blood vessels